amylin glp-1 dual agonist Frontiers Non-insulin injectable antidiabetic drugs -
Description
Nausea: the most common early side effect Nausea affects 30% to 50% of GLP-1 users at some point during treatment
EClinicalMedicine 69, 102475
Consume Protein-Rich Foods Protein promotes GLP-1 secretion, aiding satiety and blood sugar control
A metabolic issue that increases your risk of cancer, diabetes, dementia, and yes, even a shorter life span
Kim M, Kim SC, Kim J, Kim BH
At the beginning of the study, 20% were in therapy for OSA
